We examined morphological alterations in the mitochondria in the spinal cord of H46R mutant Cu/Zn superoxide dismutase transgenic mice; these mice serve as a model for human familial amyotrophic lateral sclerosis. The disease in the mice is characterized by initial muscle weakness and atrophy in the legs, very long clinical courses, and widespread pathological changes of the spinal cord that extend beyond the motor system and includes many neuropil aggregates that lack vacuoles. At the preclinical stage, we found alterations in the mitochondrial cristae that included focal electrondense changes, whorled membranous and electron-dense amorphous structures, and outward projections of outer and inner membranes predominantly in proximal axons. At the overt disease stage, these mitochondrial alterations were more frequent and were also found in somata, dendrites, presynaptic terminals, and astrocyte cytoplasm. By immunoelectron microscopy, no accumulations of Cu/Zn superoxide dismutaseY or ubiquitin-positive immunogold particles were observed in either normal-appearing or abnormal mitochondria. These findings suggest that predominant mitochondrial alterations in the proximal axons begin in the preclinical stage and may be involved in the pathogenetic mechanisms of motor neuron degeneration in these transgenic mice via disruption of the axonal transport of substrates necessary for neuronal viability; this disruption may lead to motor neuron death.
INTRODUCTION
Familial amyotrophic lateral sclerosis (FALS) with a novel point mutation (H46R) in exon 2 of the Cu/Zn superoxide dismutase (SOD1) gene is an autosomal dominant disorder that has been reported in the Japanese population. Patients with FALS who have an H46R SOD1 mutation are characterized clinically as having a ''pseudopolyneuritic form of amyotrophic lateral sclerosis (ALS),'' that is, with lower motor neuron-dominant involvement developing in the lower extremities and remarkably long clinical courses of approximately 15 years (1Y3). Transgenic (Tg) mice with this mutation exhibit widespread changes that extend beyond the motor system to involve the entire white matter of the spinal cord and the anterior and posterior roots; these findings are accompanied by numerous SOD1-and ubiquitin-positive aggregates lacking vacuoles in the neuropil (4) . Recently, accumulating evidence has indicated that mitochondrial damage is involved in motor neuron degeneration in sporadic ALS (5Y7), FALS with a SOD1 mutation (8, 9) , and in mutant SOD1 Tg mice (10, 11) . There, currently, is no information, however, on morphological alterations in the mitochondria of H46R mutant SOD1 Tg mice. This is the first report to focus on the fine structural alterations of mitochondria in motor neurons and their neuronal processes and astrocytes in H46R mutant SOD1 Tg mice.
MATERIALS AND METHODS

Experimental Animals and Clinical Assessment
All mice were handled according to approved animal protocols of the Tohoku University Graduate School of Medicine (the Recombinant DNA Experiment Safety Committee including Animal Experimental Committee). The processes of development and clinical assessment of H46R mutant SOD1 Tg mice have been previously reported (4) . Briefly, the DNA of newborn mice was extracted from their tails, and polymerase chain reaction amplification (forward primer: 5 ¶-TTGGG AGGAGGTAGTGATTA; reverse primer: 5 ¶-AGCTAGCAG GATAACAGATGA; 94-C for 30 seconds; 55-C for 30 seconds; 72-C for 30 seconds; 30 cycles) and Southern blotting were used to detect the exogenous human SOD1 transgene.
To generate Tg mice with the H46R mutation, we first obtained human genomic P1 artificial chromosome (PAC) clones encompassing the entire human SOD1 gene; we then subcloned this gene within an 11.5-kb EcoRI-BamHI fragment. Site-directed mutagenesis was used to generate clones with the H46R mutation. The mutated 11.5-kb EcoRI-BamHI fragments were microinjected into fertilized eggs from B6D2F1/Crlj (BDF1) mice; 83 potential Tg H46R pups were obtained. From these, 3 founders with the H46R mutant Copyright @ 2009 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited.
transgene were identified using polymerase chain reaction and Southern blotting. One line with the H46R mutation developed motor neuron disease. This line expressed the highest level of the mutant SOD1.
The first sign of disease in this mutant line was weakness of limbs that was primarily indicated by the dragging of 1 limb. In the H46R-70 line, all of the mice showed weakness in their hind limbs. The mean age at which this clinical weakness appeared was 153 T 10.0 days (n = 4). As the disease progressed, the mice exhibited marked muscle wasting in their limbs. Thereafter, the other limbs also became weak. At the end stage of disease, the affected mice were unable to move toward water to drink and they died. The mean age at death in the H46R-70 line was 184 T 11.8 days (n = 4). The mean duration of the clinical expression of the disease in the H46R-70 was 27.5 T 8.2 days (n = 4). The lines that expressed lower levels of human mutant SOD1 did not show any clinical signs up to 12 months of age. A total of 19 Tg mice and 18 nontransgenic (non-Tg) mice were studied.
Histopathology
Eight Tg mice and 8 age-matched non-Tg mice were studied by histopathology. The Tg mice were divided into 4 groups as follows: early preclinical (aged 12 weeks, n = 2), late preclinical (16 weeks, n = 2), early clinical (20 weeks, n = 2), and end-stage (24 weeks, n = 2) Tg mice. Agematched non-Tg mice served as controls in each group; Tg and non-Tg mice were examined at the same time. The mice were deeply anesthetized with ether and perfused intracardially with heparinized saline (pH 7.4), followed by perfusion with ice-cold 4% paraformaldehyde (Katayama Chemical, Osaka, Japan) in 0.1 M phosphate buffer (pH 7.4). The spinal cords were removed rapidly and postfixed by immersion in the same fixative (5 days, 4-C). Cross-sections of the spinal cord were embedded in paraffin, sectioned (4 Km), and subsequently stained with hematoxylin and eosin (H&E) and with Klüver-Barrera stain.
Electron Microscopy
Eight Tg and 8 non-Tg wild-type mice were killed at ages 12, 16, 20, and 24 weeks (n = 2 in each group, respectively). All mice were perfused intracardially with heparinized saline (pH 7.4), followed by perfusion with ice-cold 4% paraformaldehyde (Katayama Chemical) and 0.2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). Tissues of the spinal cord were incubated in 2% osmium tetroxide in 0.1 M cacodylate for 2 hours, washed, dehydrated, and embedded in epoxy resin. Serial semithin sections (1 Km thick) of the whole transverse spinal cord stained with toluidine blue were examined under a light microscope. The spinal cord sections (including the anterior and posterior horns, anterior, lateral and posterior columns, and anterior and posterior roots) were cut into ultrathin sections that were subsequently stained with uranyl acetate and lead citrate.
Semiquantitative analysis of the incidence of abnormal mitochondria was performed in 1,000 normal-appearing myelinated axons with a diameter of more than 3 Km (i.e. the mean of the shortest and the largest diameters of an axon) within the anterior column of the lumbar spinal cord at each stage of Tg mice, respectively, making a total of 4,000 myelinated axons.
Immunoelectron Microscopy
Postembedding immunogold electron microscopy was carried out on spinal cord specimens. Late preclinical (16 weeks, n = 1), early clinical (20 weeks, n = 1), and endstage (24 weeks, n = 1) mice were perfused as described above for electron microscopy. Two non-Tg wild-type mice (20 weeks, n = 1; 24 weeks, n = 1) served as controls. The lumbar and cervical spinal cords were dissected out, dehydrated in 100% ethanol, and embedded in hard-grade LR White resin (Electron Microscopy Sciences, Fort Washington, PA) by polymerization overnight at 60-C. Ultrathin sections were excised from the embedded tissue using a microtome and were collected onto grids (150 mesh). The ultrathin sections were then etched in 0.1 N HCl for 5 minutes, rinsed 3 times for 5 minutes each in Tris-buffered saline (TBS) (20 mM Tris, 140 mM NaCl, and 2.7 mM KCl, pH 8.0), treated with blocking buffer (0.1% gelatin, 1% normal goat serum, and 0.3% Triton-X-100 in TBS) for 30 minutes, incubated with the primary antibodies for 2 hours at room temperature, rinsed 3 times for 5 minutes each in TBS, placed in gold-conjugated secondary antibody (10-nm gold anti-mouse anti-rabbit) for 1 hour, rinsed 3 times in TBS, rinsed in water, and stained with uranyl acetate and lead citrate. The following antibodies and sera were used: sheep polyclonal anti-human SOD1 antibody (Calbiochem, San Diego, CA) at 1:500, 1:1000, or 1:2000 dilution; a polyclonal anti-ubiquitin antibody (DAKO, Carpinteria, CA) diluted at 1:100, 1:500, or 1:1000; and a monoclonal anti-phosphorylated neurofilament antibody (DAKO) diluted at 1:50, 1:100, 1:500, and normal rabbit serum (Vector Laboratories, Burlingame, CA).
RESULTS
Light Microscopic Findings
Light microscopic findings have been previously reported (4) . Briefly, in 12-week-old (early preclinical stage) mice, H&E and Klüver-Barrera staining revealed no pathological changes anywhere in the spinal cord. In Epon-embedded plastic sections stained with toluidine blue, however, there were rare aggregates detected in the neuropil of the anterior horns and around the central canal but not in the posterior horns or white matter. The anterior and posterior roots showed no abnormalities.
In 16-week-old (late preclinical stage) mice, H&E and Klüver-Barrera staining revealed no pathological changes in either the gray matter or the white matter, and no neuronal loss was observed anywhere in the spinal cord; SOD1-and ubiquitin-positive inclusions without cores (aggregates) and eosinophilic, SOD1-and ubiquitin-positive inclusions with cores (Lewy body-like inclusions [LIs]) were, however, rarely observed by H&E staining. In plastic sections, aggregates, LIs, spheroids, and cord-like swollen axons were occasionally seen in the neuropil in the anterior horns. Myelin ovoids were only occasionally observed in all white matter examined, but the anterior and posterior roots were intact.
In 20-week-old (early clinical stage) and 24-week-old (end stage) mice, the average numbers of large anterior horn neurons were significantly less than in the controls. Aggregates and LIs were frequently observed in the neuropil of the anterior horn. In plastic sections, aggregates, LIs, spheroids, and cord-like swollen axons were frequently seen in the neuropil of the anterior horns. Aggregates and LIs were also observed in the posterior horns and in the white matter of the anterior, lateral, and posterior columns at the end stage. Swollen axons (spheroids) were prominent at the exit zone of the anterior roots in the anterior columns as well as in the anterior horns. Myelin ovoids and degenerated fibers were prominent in the anterior roots and posterior roots, as well as in the white matter of the anterior, lateral, and posterior columns, including in the pyramidal tract over time. No vacuolar changes were observed anywhere at any stage of disease progression.
Electron Microscopic Findings Non-Tg littermates
Mitochondria in neuronal perikarya, dendrites, and axons were well preserved and surrounded by an outer unit membrane and an inner, folded membrane that formed the cristae; the latter were filled with a dense matrix (Fig. 1) . The intermembrane space was generally lucent. Disorganization or small vacuolar changes in the inner compartment and whorled membranous structures were only occasionally seen in the spinal cord gray and white matter and the anterior and posterior roots. Electron-dense changes of cristae and electrondense amorphous structures were rare anywhere in the spinal cord of non-Tg mice.
Tg mice
Mitochondria were also well preserved. In 12-week-old mice, mitochondria were almost always normal in structure; large, swollen mitochondria with an increased number of cristae ( Fig. 2) and mitochondria with disorganized inner compartment (Fig. 3) or whorled membranous structures were only occasionally observed. These abnormalities were predominantly in the gray and white matter axons and the anterior and posterior roots and, to a lesser degree, in dendrites and somata of anterior horn neurons. Electron-dense changes of cristae were rarely found anywhere.
In 16-week-old mice, swollen mitochondria were more numerous than in younger mice. Mitochondria with a disorganized inner compartment or whorled membranous structures were only occasionally observed in the axons of the gray and white matter and the anterior and posterior roots. Mitochondrial alterations in the cristae were occasionally observed in the proximal axons of the anterior horns.
In 20-week-old mice, enlarged mitochondria with increased numbers of cristae and mitochondria with a disorganized inner compartment were less prominent in the neuronal processes and somata of the anterior horn neurons. The intermembrane space was occasionally dilated and contained membranous structures (Fig. 4) . Mitochondria with whorled membranous structures were occasionally observed in anterior and posterior horns, anterior and lateral columns, FIGURE 1. Nontransgenic littermate (24 weeks). The mitochondria in an axon are well preserved and surrounded by an outer smooth unit membrane and an inner folded membrane that forms the cristae that are filled with a dense matrix. The intermembrane space is generally lucent. Scale bar = 1 Km. and anterior roots to a greater extent than in the posterior columns and roots. Alterations in the cristae, that is, focal electron-dense changes (Fig. 5 ) and electron-dense amorphous structures, were more frequently observed in the proximal axons of the anterior horns, the anterior and lateral columns, and the anterior roots and, to a lesser degree, the posterior horns and the posterior column than in the 16-weekold mice. Electron-dense changes of cristae were not found in the posterior roots. Slight focal, outward projections of both the inner and outer membranes were observed on both transverse and longitudinal sections (Fig. 6) .
In 24-week-old mice, focal electron-dense changes in the cristae, whorled membranous structures (Fig. 7) , and electron-dense amorphous structures (Fig. 8 ) became prominent in the anterior horns, the anterior and lateral columns, and the anterior roots and, to a lesser degree, the posterior structures; the entire interior of the mitochondria frequently appeared to be electron-dense membranous or amorphous structures (Fig. 9) . These inner and outer membrane structures projected prominently outward (Fig. 10) . These changes were frequently observed not only in proximal axons but also in the somata of large and small anterior horn neurons, dendrites (Fig. 11) , and presynaptic terminals on the surface of anterior horn cells (Fig. 12) . The alterations in the cristae were more frequent in degenerative motor neurons that showed central chromatolysis than in normal-looking motor neurons at any stage. Astrocytes occasionally contained mitochondria that showed swellings, disorganization of inner compartments, and electron-dense membranous or amorphous structures of cristae in the cytoplasm at this stage (Fig. 13) .
Semiquantitative Analysis of the Incidence of Abnormal Mitochondria
Mitochondrial alterations were most frequently observed in the anterior columns. Therefore, we carried out a semiquantitative analysis of the incidence of abnormal mitochondria in the anterior column of the lumbar spinal cord (Table) . We investigated 1,000 normal-looking myelinated axons at each stage, making a total of 4,000 myelinated axons. In 12-week-old mice, a total of 2,612 mitochondria were observed in 1,000 myelinated axons. The average number of mitochondria was 2.61 T 1.80. Focal electron-dense changes in the cristae (Fig. 5 ) and whorled membranous structures (Fig. 7) were observed in 5 (0.19%) and 19 (0.73%) mitochondria, respectively.
In 16-week-old mice, a total of 2,611 mitochondria were observed. The average number of mitochondria was 2.61 T 1.88. Focal electron-dense changes in the cristae and whorled membranous structures were observed in 4 (0.15%) and 41 (1.57 %) mitochondria, respectively. The outward projection of the inner and outer membranes (Fig. 10) was observed in 5 (0.19%) mitochondria.
In 20-week-old mice, a total of 1,880 mitochondria were observed. The average number of mitochondria was 1.88 T 1.59. Alterations in the cristae such as focal electrondense changes and electron-dense amorphous structures (Fig. 8) were observed in 60 mitochondria (3.19%). Whorled membranous structures and the outward projection of the inner and outer membranes (Fig. 10) were observed in 44 (2.34%) and 17 (0.90%) mitochondria, respectively.
In 24-week-old mice, a total of 1,666 mitochondria were observed. The average number of mitochondria was 1.67 T 1.38. Alterations in the cristae such as focal electrondense changes and electron-dense amorphous structures were observed in 158 mitochondria (9.48%). Whorled membranous structures and the outward projection of the inner and outer membranes were observed in 61 (3.66 %) and 5 (0.30%) mitochondria, respectively.
Thus, the incidence of abnormal mitochondria increased from the preclinical to overt clinical stages. The incidence of whorled membranous structures and outward projection of the inner and outer membranes significantly increased in the late preclinical stage compared with the early preclinical stage (Fisher exact test, p G 0.05). In the overt clinical disease stages, abnormalities of all the mitochondrial components significantly increased compared with those in the early stage (Fisher exact test, p G 0.01). 
Immunoelectron Microscopic Findings
To determine the ultrastructural distribution of human SOD1 and ubiquitin immunoreactivity, we used postembedding immunogold electron microscopy. Abundant human SOD1 and ubiquitin immunogold labeling was observed in the profiles of small to large aggregates (Fig. 14) even in samples obtained at the preclinical stage. Cu/Zn superoxide dismutase and ubiquitin determinants were undetectable in both most normal-appearing mitochondria (Fig. 14) and in degenerated or abnormal mitochondria (Fig. 15) , although rare mitochondria showed SOD1-immunogold labeling (Fig. 16) .
No phosphorylated neurofilament immunogold labeling was detected in the aggregates, LIs, or the mitochondria. No control mice at any age showed SOD1-or ubiquitin-positive aggregates, LIs, or cord-like axonal swelling.
DISCUSSION
Accumulating evidence strongly suggests that mitochondrial dysfunction plays a role in the pathogenetic mechanisms of motor neuron degeneration in ALS (5Y10). Functional abnormalities including elevated levels of mutant mitochondrial DNA in the spinal cord (7) and the motor cortex (9), reduced mitochondrial DNA in the spinal cord (7), changes in the activity of complex I of the mitochondria respiratory chain in familial ALS patients (8, 12) , decreased complex IV activity in the spinal motor neurons of sporadic ALS patients (13, 14) , and the possible involvement of some mitochondrial haplotype variations in the risk of ALS development (15) have been reported. An out-of-frame mutation of mitochondrial DNA encoding subunit I of cytochrome c oxidase in a patient with motor neuron disease has also been reported (16) . Mitochondrial dysfunction can lead to increased cytosolic calcium levels as a result of cellular depolarization (17) which would most likely result in motor neuron death, because large motor neurons do not contain calcium-binding proteins such as parvalbumin and calbindin D-28k and are less able to buffer calcium (18) . Moreover, the vulnerability of motor neurons to excitotoxicity is selectively enhanced when mitochondrial function is impaired (19) .
There have been several observations of morphological mitochondrial abnormalities in sporadic ALS patients. These include bizarre giant mitochondria in liver biopsy specimens (20, 21) , abnormal accumulation of mitochondria in the axon hillock and the initial segment of axons (22), conglomeration of dark abnormal mitochondria at the presynaptic terminals of anterior horn neurons (5), and mitochondria with increased volumes in muscle biopsies (6) . We recently reported several morphological changes in the mitochondria in the somata of the anterior horn neurons and neuronal processes in patients with sporadic ALS, including a stack of multilayered, linear cristae in the mitochondria in the somata of anterior horn neurons and their axons (23) , swollen mitochondria with markedly increased cristae in the somata of the anterior horn neurons (23) , and increased numbers of unusual inclusion bodies consisting of tubular structures of the mitochondrial cristae in the somata of dorsal root ganglion cells in sporadic ALS patients (24) . The morphological changes in the mitochondria of H46R mutant SOD1 Tg mice are, however, quite different from those in sporadic ALS (23, 24) , but markedly swollen mitochondria with increased numbers of cristae have been seen in both diseases.
There is also accumulating evidence that mitochondria are a major target of mutant SOD1 toxicity. In mice possessing high copy numbers of the G93A transgene and G37R mutant SOD1, both mitochondrial swelling and vacuolation begin at early stages of disease (11, 25) and peak at the onset of muscle weakness (10) . In cultured neuroblastoma cells or motor neurons, the expression of mutant SOD1 causes mitochondrial damage and dysfunction (26, 27) . Furthermore, various mitochondrial electron transport chain activities are decreased in the anterior horn before the disease onset and during the stage of disease progression (28) . Thus, mitochondrial abnormalities may play an early role in pathways leading to cell death, or may occur as a consequence of other subtle impairments and contribute to mechanisms of chronic neurodegeneration (29) . In this study, we demonstrated that all components of the mitochondria in the spinal cords of H46R mutant SOD1 Tg mice are altered. In particular, electron-dense changes of cristae were intriguing findings that were predominantly recognized in axons starting at the preclinical stage and progressing later through the overt clinical stage. These alterations were subsequently also observed in the somata, dendrites, presynaptic terminals, and astrocyte cytoplasm at the later stages. The alterations in the cristae may reflect a disturbance in energy generation related to enzymes of the respiratory electronYtransport chain that are attached to the cristae and project into the matrix. Furthermore, outer mitochondrial membrane damage probably results in membrane permeabilization, which is lethal because it triggers the release of caspase-activating molecules and caspase-independent death effectors, metabolic failure in the mitochondria, or both (30) . Thus, these structural changes in the mitochondria may reflect mitochondrial dysfunction in the motor neurons and be related to the neurodegeneration in these mutant mice. These electron-dense alterations of cristae are characteristic of these H46R SOD1 Tg mice and contrast to the vacuolar changes predominant in Tg mice that express high levels of G93A mutant SOD1 (10, 25, 31Y33) and G37R mutant SOD1 (11) . On the other hand, G93A mutant SOD1 Tg mice with a low transgene copy number (34) and G85R mutant SOD1 Tg mice (35) showed no vacuoles, which is also the case in H46R mutant SOD1 Tg mice. These findings suggest that the mitochondria may undergo morphologically protean alterations according to differences in SOD1 mutations, different levels of SOD1 toxicity, and at different disease stages. The predominance of these mitochondrial abnormalities in the proximal axons even at preclinical stage observed in this study implies a disruption of axonal transport of the substrates needed for neuronal viability starting at the preclinical stage that eventually leads to motor neuron degeneration. Predominant abnormalities of the mitochondria in the proximal axons are also reminiscent of those in Tg mice, with a relatively low transgene copy number expressing a G93A mutant human SOD1; these latter mice predominantly exhibit vacuoles in the mitochondria of the axons but not in the somata of anterior horn cells or in their dendrites at any stage of disease (31) . Our present finding that mitochondrial alterations exhibited in the anterior horn neurons and neuronal processes are also observed in astrocyte cytoplasm at the overt clinical stage in this study is also intriguing. Similar mitochondrial alterations have not been detected in the astrocytes of G93A mutant SOD1 Tg mice (31), whereas accumulating evidence suggests that non-neuronal cells such as astrocytes might directly contribute to the neuronal loss and have prominent roles in the neurodegenerative disorders that are often characterized by distinctive local astrocytosis (36) . One of the potential candidates for pathogenic mechanisms in ALS has also been linked to neuronal excitotoxicity from excessive extracellular glutamate due to the dysfunction of astrocytic glutamate transporters (37) . Toxicity to motor neurons is known to be noncell autonomous because wildtype non-neuronal cells can delay or eliminate degeneration and death of SOD1 mutant-expressing motor neurons and wild-type neurons acquiring damage from mutant-expressing neighbors (38) . Thus, our findings of mitochondrial abnormalities in astrocytes suggest that impairment of astrocytes may also influence motor neuron degeneration or death.
Some immunoelectron-microscopic studies have indicated that SOD1 is distributed throughout the cytoplasm, in the nucleus, and in peroxisomes but not in the mitochondria (39, 40) , whereas other studies indicate that SOD1 is present inside mitochondria (28, 41Y43) and that mutant SOD1 is associated with abnormal mitochondria in the central nervous system of mice (32, 44) . In G93A mutant Tg mice and miceexpressing wild-type human SOD1, far more SOD1-immunogold particles are present in the mitochondria than in the mitochondria of their non-Tg littermates (31, 33, 41) , suggesting that the altered mitochondria of Tg mice are closely associated with SOD1-induced motor neuron degeneration. In the present study, SOD1-immunogold particles were not observed either in normal-appearing or abnormal mitochondria, which suggests that SOD1-induced neurotoxicity may not be directly related to mitochondrial degeneration, but that mitochondrial alterations may be secondarily caused by the mutation in H46R mutant SOD1 Tg mice.
Mitochondria are known to play complex roles in the pathogenesis of neurodegenerative diseases due to their involvement in the regulation of excitotoxicity, the homeostasis of intracellular Ca 2+ , reactive oxygen species production, and apoptotic processes. The significance of the mitochondrial abnormalities observed here and their connection with oxidative stress, excitotoxicity, and mitochondrial apoptosis in H46R mutant SOD1 Tg mice remain to be elucidated. The demonstration of mitochondrial damage in H46R mutant SOD1 Tg mice, whether these abnormalities are primary or secondary, suggests that therapeutic compounds capable of modulating or rescuing mitochondrial function may exert a protective function or even prevent the degeneration of motor neurons.
